ALX Oncology Holdings Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AVTE
|
Aerovate Therapeutics, Inc. | $2.67 | $597.48 M | -6.84 | 51 | $0 |
 BCAB
|
BioAtla, Inc. | $1.57 | $73.14 M | -0.61 | 65 | $0 |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.55 | $291.95 M | -3.13 | 54 | $0 |
 BMEA
|
Biomea Fusion, Inc. | $6.43 | $148.81 M | -1.17 | 107 | $0 |
 CABA
|
Cabaletta Bio, Inc. | $1.89 | $508.83 M | -6.16 | 136 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $4.25 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $56.02 | $3.53 B | -11.86 | 290 | $4.01 M |
 DYN
|
Dyne Therapeutics, Inc. | $29.67 | $3.03 B | -7.77 | 173 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.23 | $1.65 B | -11.47 | 108 | $0 |
 EYPT
|
EyePoint Pharmaceuticals, Inc. | $8.94 | $473.97 M | -5.03 | 121 | $46.02 M |
 IMTX
|
Immatics N.V. | $7.58 | $1.36 B | -12.3 | 542 | $54.00 M |
 IPSC
|
Century Therapeutics, Inc. | $1.20 | $244.54 M | -1.32 | 152 | $2.24 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 PASG
|
Passage Bio, Inc. | $0.51 | $73.04 M | -0.77 | 58 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |
 VIRX
|
Viracta Therapeutics, Inc. | $0.16 | $24.19 M | -0.5 | 40 | $0 |